Target intelligence / Profile preview

Influenza A virus neuraminidase subtype N1 (H5N1) (NA)

Target
NA
Molecular classification
Enzyme (glycoside hydrolase, EC 3.2.1.18), Viral surface protein, Tetrameric glycoprotein
01

Overview

Neuraminidase is a tetrameric glycoprotein and exosialidase (EC 3.2.1.18) found on the surface of the influenza A virus, including the H5N1 subtype. Each monomer is about 470 amino acids (~60 kDa), forming a mushroom-shaped tetramer. It plays a critical role in viral pathogenesis by cleaving α-ketosidic linkages between sialic acid and adjacent sugar residues on the host cell surface and on viral glycoproteins, promoting the release and dissemination of progeny virions after budding. Neuraminidase and hemagglutinin define the subtype and antigenic profile of influenza A viruses. Its enzymatic activity is essential for viral spread and is the target of several important antiviral drugs (neuraminidase inhibitors). NA subtypes, especially N1, are closely associated with zoonotic potential and the risk of pandemic spread. Resistance, arising primarily from mutations at key active-site residues, poses an ongoing therapeutic challenge.

Other names
neuraminidaseviral neuraminidaseinfluenza virus neuraminidaseN1 neuraminidaseavian influenza neuraminidasesialidase
02

Mechanism of action

Competitive inhibition of the enzymatic active site, preventing cleavage of sialic acid residues and thus blocking release of viral progeny and limiting viral spread

03

Biological functions

Viral release from host cellsCleavage of terminal sialic acids from glycoproteins and glycolipidsPrevention of viral aggregationMaintenance of functional balance with hemagglutinin for efficient infection
04

Disease associations

Infection (influenza A, including pandemic/zoonotic strains such as H5N1)
05

Safety considerations

Rapid development of drug resistance via mutations in the active site (e.g., H274Y)Limited antiviral efficacy in some influenza strains or when resistance emergesNecessity for early drug administration to be effective
06

Interacting drugs

Oseltamivir (Tamiflu)

3 more in the full profile.

07

Biomarkers

Neuraminidase inhibitor resistance mutations (e.g., H274Y substitution in N1)NA enzyme activity assays (used to monitor drug resistance and viral fitness)

Beyond the preview

Go deeper on Influenza A virus neuraminidase subtype N1 (H5N1) (NA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus neuraminidase subtype N1 (H5N1) (NA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call